Astaxanthin /æstəˈzænθɪn/ is a keto-carotenoid within a group of chemical compounds known as carotenoids, a subclass of the broad group of phytochemicals known as terpenes. Astaxanthin is a metabolite of zeaxanthin and canthaxanthin, containing both hydroxyl and ketone functional groups.
It is a lipid-soluble pigment with red coloring properties, which result from the extended chain of conjugated (alternating double and single) double bonds at the center of the compound. The presence of the hydroxyl functional groups and the hydrophobic hydrocarbons render the molecule amphiphilic.
Astaxanthin is produced naturally in the freshwater microalgae Haematococcus pluvialis, the yeast fungus Xanthophyllomyces dendrorhous (also known as Phaffia rhodozyma) and the bacteria Paracoccus carotinifaciens. When the algae are stressed by lack of nutrients, increased salinity, or excessive sunshine, they create astaxanthin. Animals who feed on the algae, such as salmon, red trout, red sea bream, flamingos, and crustaceans (shrimp, krill, crab, lobster, and crayfish), subsequently reflect the red-orange astaxanthin pigmentation.
Astaxanthin is used as a dietary supplement for human, animal, and aquaculture consumption. Astaxanthin from algae, synthetic and bacterial sources is generally recognized as safe in the United States. The US Food and Drug Administration has approved astaxanthin as a food coloring (or color additive) for specific uses in animal and fish foods. The European Commission considers it as a food dye with E number E161j. The European Food Safety Authority has set an Acceptable Daily Intake of 0.2 mg per kg body weight, as of 2019. As a food color additive, astaxanthin and astaxanthin dimethyldisuccinate are restricted for use in Salmonid fish feed only.
Safety at a Glance
- Toxicity: Astaxanthin has one of the most favorable safety profiles of any carotenoid supplement, supported by extensive use in...
- Start with a low dose and wait for onset before redosing
- Test your substance with reagent kits when possible
- Never use alone — have a sober person present
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
Oral
Duration
Oral
Total: 24 hrs – 48 hrsSubjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(1)
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Pharmacology
Astaxanthin is a xanthophyll carotenoid (keto-carotenoid) produced primarily by microalgae (Haematococcus pluvialis), which concentrate it under stress conditions. Marine animals including salmon, shrimp, krill, and flamingos acquire their pink-orange coloration from dietary astaxanthin.
Antioxidant mechanism: Astaxanthin's extraordinary antioxidant potency (estimated 6,000x stronger than vitamin C, 800x stronger than CoQ10 for singlet oxygen quenching) derives from its unique molecular structure. The conjugated polyene chain efficiently quenches singlet oxygen and scavenges free radicals through electron donation, while the polar keto and hydroxyl end groups anchor the molecule in the cell membrane, spanning its full width. This orientation protects both the hydrophilic membrane surface (where water-soluble oxidants attack) and the hydrophobic lipid bilayer core (where lipid peroxidation chain reactions propagate) simultaneously. Vitamin E and most other lipophilic antioxidants only protect the lipid core; vitamin C only protects the aqueous phase.
Nrf2 pathway: Astaxanthin activates Nrf2 (nuclear factor erythroid 2-related factor 2), the master transcription factor for antioxidant defense genes, upregulating heme oxygenase-1 (HO-1), glutathione synthesis enzymes (GCL), glutathione peroxidase, thioredoxin reductase, and NAD(P)H quinone dehydrogenase 1 (NQO1). This transcriptional response multiplies astaxanthin's direct antioxidant effects through induction of endogenous antioxidant enzymes.
Anti-inflammatory: Astaxanthin inhibits NF-kappaB signaling (a primary inflammatory transcription factor), suppresses COX-2 and iNOS expression (reducing prostaglandin and nitric oxide production), and reduces inflammatory cytokine release (IL-1β, IL-6, TNF-alpha). These mechanisms have been validated in numerous cell culture, animal, and human studies.
Blood-brain barrier crossing: Unlike most carotenoids (beta-carotene cannot cross the BBB), astaxanthin's amphipathic membrane-spanning orientation facilitates its integration into lipid bilayers including the BBB, enabling CNS accumulation and neuroprotection.
Retinal protection: Astaxanthin accumulates in retinal tissue and protects photoreceptors from light-induced oxidative damage (particularly singlet oxygen generated during phototransduction). This provides the mechanistic basis for reported improvements in visual acuity and eye fatigue.
Interactions
No documented interactions.
History
Astaxanthin was first isolated in 1938 by the British chemist Richard Kuhn (Nobel Prize in Chemistry, 1938, primarily for work on carotenoids and vitamins) from lobster (Astacus species — hence the "astax" prefix from Astacus). Kuhn characterized its structure as a carotenoid with keto and hydroxyl substituents on the ionone rings.
The pigment's role in animal coloration was studied throughout the mid-20th century: salmon's pink flesh, flamingo feathers, and crustacean shells are all colored by astaxanthin accumulated from dietary microalgae through the food chain. The 1962 recognition that salmon and trout require dietary astaxanthin for their distinctive coloration (without it, their flesh is white) established astaxanthin's commercial significance in aquaculture.
The aquaculture industry became the primary commercial driver: synthetic astaxanthin (produced by Hoffmann-La Roche and others) was developed in the 1980s and used extensively as a feed additive to produce the pink flesh consumers expected in farmed salmon. This large-scale use provided extensive (if largely unintentional) safety data.
Scientific interest in astaxanthin's antioxidant and health properties grew from the late 1980s, when Japanese researcher Yasuhiro Miki and colleagues characterized its singlet oxygen quenching capacity in 1991, finding it substantially more potent than other carotenoids. This paper sparked the research trajectory that ultimately led to over 1,000 scientific publications on astaxanthin's health properties.
Natural astaxanthin production from Haematococcus pluvialis microalgae (which accumulate massive amounts under stress) was developed commercially in Hawaii and Israel in the 1990s–2000s, positioning natural astaxanthin as a premium alternative to synthetic aquaculture-grade product. The supplement market for natural astaxanthin grew rapidly in the 2000s–2020s, reaching hundreds of millions in annual sales globally, driven particularly by interest in Japan (where astaxanthin from Cyanotech and similar manufacturers is one of the most popular anti-aging supplements).
Harm Reduction
Lipid-soluble absorption optimization. Astaxanthin is highly lipophilic and requires dietary fat for absorption. Take with a meal containing fat (avocado, olive oil, nuts, fish) to maximize bioavailability. Studies show 3–4-fold higher plasma levels with fat co-administration versus fasting.
Standard doses. Clinical trials showing benefits (cognitive, anti-inflammatory, visual, exercise performance) typically use 4–12 mg/day of natural astaxanthin. Higher doses (up to 20–40 mg/day) have been used safely but with diminishing marginal benefit and increased cost. The established EFSA guideline of 8 mg/day provides good guidance.
Natural vs. synthetic. Natural astaxanthin (from H. pluvialis algae) is predominantly the 3S,3'S stereoisomer (the same as in marine animals). Synthetic astaxanthin (used in aquaculture) is a racemic mixture of stereoisomers. Natural astaxanthin may have superior biological activity, though direct head-to-head comparison in humans is limited. Most high-quality supplements specify natural astaxanthin.
Consistency over time. Antioxidant and anti-inflammatory effects of astaxanthin are typically evaluated in studies of 4–16 weeks duration. Benefits accumulate over weeks of consistent use. Short-term or intermittent use is less likely to show measurable effects.
No concern about carotenoid stacking. Unlike high-dose beta-carotene (which showed increased lung cancer risk in smokers — the SELECT trial for smokers), astaxanthin does not convert to vitamin A and does not share the same concerns. It can be used alongside other carotenoids (lutein, lycopene, beta-carotene in moderate amounts) without concern.
Retinal health context. For visual health applications (eye fatigue, dry eyes, visual acuity), astaxanthin is typically studied as part of a carotenoid blend with lutein and zeaxanthin (the macular pigments). The combination may be more effective than astaxanthin alone.
Toxicity & Safety
Astaxanthin has one of the most favorable safety profiles of any carotenoid supplement, supported by extensive use in aquaculture (it is added to salmon feed at large scale) and by human clinical trials.
Carotenodermia: The primary cosmetic concern — as with all carotenoids consumed in large amounts — is orange-tinged skin (carotenodermia). This is benign and reversible upon dose reduction. At typical supplemental doses (4–12 mg/day), skin discoloration is generally not noticeable in humans.
No vitamin A toxicity: Unlike retinol and some provitamin A carotenoids (beta-carotene), astaxanthin cannot be converted to vitamin A in the body (it lacks the beta-ionone ring structure required for retinoid conversion). The hypervitaminosis A that limits beta-carotene supplementation is therefore not applicable to astaxanthin.
EFSA safety evaluation: The European Food Safety Authority approved synthetic astaxanthin (identical to the natural compound) as a dietary supplement up to 8 mg/day in 2020. Natural astaxanthin (H. pluvialis extract) has GRAS (Generally Recognized as Safe) status in the US.
Clinical trial safety: Doses up to 40 mg/day for 12 weeks have been used in human trials without significant adverse effects. The most common reported side effects are mild GI discomfort (nausea, loose stools) at higher doses.
Warfarin interaction: Astaxanthin may have mild antiplatelet effects. Theoretical interaction with anticoagulants warrants monitoring if using concomitantly, though this has not been well documented in clinical practice.
Pregnancy: Safety data in pregnancy are insufficient; caution is recommended.
Overall, astaxanthin is considered among the safest available antioxidant supplements, with no established serious adverse effects at recommended doses.
Addiction Potential
No addiction potential.
Tolerance
| Full | Not applicable — nutritional supplement |
| Half | N/A |
| Zero | N/A |
Cross-tolerances
Legal Status
This substance is not a controlled or scheduled substance in any major jurisdiction. It is widely available as a dietary supplement, food additive, or over-the-counter product in the United States, United Kingdom, European Union, Canada, and Australia. In the US, it falls under the Dietary Supplement Health and Education Act (DSHEA) of 1994 and is regulated by the FDA as a dietary supplement rather than a drug. Manufacturers are responsible for ensuring safety and accurate labeling, but pre-market approval is not required.
In the European Union, it is regulated under the Food Supplements Directive (2002/46/EC) and may be subject to maximum permitted levels set by individual member states. In the United Kingdom, it falls under the Food Supplements (England) Regulations 2003 and similar devolved legislation. In Australia, it is typically listed on the Australian Register of Therapeutic Goods (ARTG) as a complementary medicine or is available as a food product. In Canada, it may be classified as a Natural Health Product (NHP) requiring a product license from Health Canada.
No prescription is required in any of these jurisdictions, and there are no criminal penalties associated with possession, purchase, or use.
Tips (2)
Inform your healthcare provider about Astaxanthin supplementation, especially before surgery or when starting new medications. Some supplements interact with drugs or affect blood clotting.
Consider whether Astaxanthin is better absorbed with food or on an empty stomach. Fat-soluble nutrients need dietary fat for absorption. Taking supplements correctly improves bioavailability significantly.
See Also
References (3)
- PubChem: Astaxanthin
PubChem compound page for Astaxanthin (CID: 5281224)
pubchem - Astaxanthin - TripSit Factsheet
TripSit factsheet for Astaxanthin
tripsit - Astaxanthin - Wikipedia
Wikipedia article on Astaxanthin
wikipedia